IN8BIO INC. - COMMON

IN8bio Completes Dosing of First Cohort in Phase 1 Clinical Trial with Allogeneic Gamma Delta T-Cell Therapy in Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant

11 أغسطس 2021 08:00:01 بحسب Nasdaq GlobeNewswire

IN8bio Appoints Emily Fairbairn and Luba Greenwood to Board of Directors

04 أغسطس 2021 08:00:01 بحسب Nasdaq GlobeNewswire

IN8bio Announces Pricing of Initial Public Offering

30 يوليو 2021 07:00:00 بحسب Nasdaq GlobeNewswire